Author Search Results

1

hERG1 positivity and Glut-1 negativity identifies high-risk TNM stage I and II colorectal cancer patients, regardless of adjuvant chemotherapy

by Muratori L, Petroni G, Antonuzzo L, Boni L, Iorio J, Lastraioli E, Bartoli G, Messerini L, Di Costanzo F, Arcangeli A
Published 2016-10-01

Get full text

Article
2

Brain region-specific susceptibility of Lewy body pathology in synucleinopathies is governed by α-synuclein conformations

by Bartels, T., Cantlon, A., de Boni, L., Dettmer, U., Jaunmuktane, Z., Jiang, H., Kim, N., Lashley, T., Liu, L., Martin, E., Rovere, M., Sanderson, J., Sylvester, M., Wallis, A., Watson, A.H, Zaccagnini, L., Zhelcheska, K.
Published 2022

Call Number: Loading...
Located: Loading...

View Fulltext in Publisher

Article